Skip to content

Clinical trials

Recruiting Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Status: Recruiting Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20181
20193
20202
20211
20225
20233
202411
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital3
Princess Maxima Center for Pediatric Oncology3
AstraZeneca2
Chinese PLA General Hospital2
Fred Hutchinson Cancer Center2
National Cancer Institute (NCI)2
Assistance Publique - Hôpitaux de Paris1
Bambino Gesù Hospital and Research Institute1
Essen Biotech1
Imviva Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma39
Leukemia, Myeloid, Acute12
Lymphoma, Non-Hodgkin7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia6
Leukemia, Biphenotypic, Acute6
Recurrence6
Myelodysplastic Syndromes5
Burkitt Lymphoma3
Hematologic Neoplasms3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.